Premium
New immunoglobulin brand for Guillain–Barré syndrome
Author(s) -
Koga Michiaki
Publication year - 2017
Publication title -
clinical and experimental neuroimmunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.297
H-Index - 15
ISSN - 1759-1961
DOI - 10.1111/cen3.12409
Subject(s) - guillain barre syndrome , open label , medicine , antibody , immunoglobulin g , immunology , clinical trial
Nomura et al. showed the efficacy and safety of freeze‐dried polyethylene glycol‐treated human immunoglobulin in a multicenter, open‐label and single‐arm trial for treatment of Guillain–Barré syndrome. Based on the results, a new source of immunoglobulin is indicated for Guillain–Barré syndrome in Japan.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom